Headaches are among the most frequent physical complaints in children and adolescents, with the prevalence increasing as children approach puberty. While the majority of pediatric headaches are primary—such as migraines or tension-type headaches—the pain physician must be adept at identifying the “red flags” that suggest secondary, life-threatening etiologies. For the board-certified physician, success depends on a developmental understanding of headache presentation and a cautious approach to pharmacological intervention.

1. Pediatric Migraine: The Developmental Presentation

The presentation of migraine in children differs significantly from the classic adult pattern, which can lead to under-diagnosis if adult criteria are strictly applied.

• Duration: Pediatric migraines are often shorter, lasting between 2 and 72 hours (compared to the 4-hour minimum in adults).
• Location: While adult migraines are typically unilateral, pediatric migraines are more commonly bilateral (frontal or bitemporal). Unilateral pain usually emerges in late adolescence.
• Autonomic Symptoms: Children are more likely to experience prominent nausea, vomiting, photophobia (sensitivity to light), and phonophobia (sensitivity to sound).
• The “Cyclical” Variants: Children may present with “Migraine Equivalents,” such as Cyclic Vomiting Syndrome or Abdominal Migraine, where the primary symptom is gastrointestinal distress rather than head pain.

2. Tension-Type and Chronic Daily Headache

Tension-Type Headaches (TTH) are common in school-age children and are often described as a “band-like” pressure around the head.

• Chronic Daily Headache (CDH): Defined as a headache occurring 15 or more days per month for at least three months.
• Medication Overuse Headache (MOH): This is a critical board topic. In children, frequent use of over-the-counter analgesics (NSAIDs or acetaminophen) more than 2-3 times per week can lead to a “rebound” phenomenon. The treatment is the complete cessation of the offending agent, which often results in a temporary worsening of symptoms before improvement occurs.

3. “Red Flags” for Secondary Headaches

Because secondary headaches can be caused by intracranial tumors, hemorrhage, or increased intracranial pressure (ICP), the clinician must screen for the following:

• Nocturnal Awakening: Headaches that wake the child from sleep or are present immediately upon awakening in the morning (suggestive of increased ICP).
• Positional Changes: Pain that worsens significantly with coughing, sneezing, or leaning forward (Valsalva maneuvers).
• Neurological Deficits: New-onset ataxia, cranial nerve palsies, or papilledema.
• Age of Onset: Very young children (under age 5) with new-onset headaches require a more aggressive workup (e.g., MRI).
• Systemic Symptoms: Fever, weight loss, or a history of malignancy.

4. Pharmacological Management: Acute and Preventive

The pharmacological strategy for pediatric headaches is more conservative than in adults, prioritizing the avoidance of side effects in the developing brain.

Acute Treatment

• NSAIDs and Acetaminophen: The first-line treatment. Early administration (at the onset of the aura or pain) is more effective than “waiting it out.”
• Triptans: (e.g., Rizatriptan or Sumatriptan nasal spray). These are selective 5-HT1B/1D receptor agonists. While many are FDA-approved for adolescents (ages 12-17), they must be avoided in patients with certain types of complex migraines (e.g., hemiplegic migraine) due to the risk of stroke.

Preventive Treatment

Indicated when headaches are frequent (e.g., >1 per week) or causing significant disability (missing school).

• Amitriptyline: A low-dose Tricyclic Antidepressant (TCA). It is highly effective but requires monitoring for side effects like sedation and, in some cases, ECG changes (QT prolongation).
• Topiramate: An anticonvulsant that is FDA-approved for migraine prevention in adolescents. High-yield side effects for boards include paresthesias, weight loss, and potential cognitive slowing (“word-finding” difficulties).
• Cyproheptadine: Often the first choice in very young children due to its favorable safety profile and its ability to stimulate appetite.

5. The Biopsychosocial Model: The “Headache Hygiene”

From a physiatric and pain management perspective, the “lifestyle” of the child is the foundation of treatment.

• Sleep Hygiene: Irregular sleep patterns are a major trigger. Establishing a consistent bedtime is often as effective as medication.
• Hydration and Nutrition: Dehydration and skipping meals (specifically breakfast) are frequent triggers.
• CBT and Biofeedback: Cognitive Behavioral Therapy (CBT) has the highest level of evidence for reducing pediatric headache frequency. Biofeedback, which teaches the child to control physiological responses to stress (like muscle tension or skin temperature), provides the child with a sense of “mastery” over their pain.

6. Cervicogenic and Post-Traumatic Headaches

Many pediatric headaches have a musculoskeletal component.

• Cervicogenic Headache: Pain referred from the upper cervical spine (C1-C3). This is common in “Tech Neck” (prolonged forward head posture while using devices).
• Post-Concussive Headache: A specific subset of headaches following mild Traumatic Brain Injury (mTBI). The PM&R focus is on a Gradual Return to Play and Return to Learn protocol, ensuring that the child’s cognitive load is balanced to avoid exacerbating symptoms.

---

High-Yield Board “Fast Facts”

• Cyclic Vomiting Syndrome: A migraine variant characterized by intense bouts of nausea and vomiting with “wellness” intervals in between.
• Bilateral Pain: The most common location for pediatric migraine (unlike the unilateral adult pattern).
• Topiramate Side Effects: Paresthesias, weight loss, and “brain fog.”
• Medication Overuse: Advise patients to limit acute meds to <10 days per month.